First Capital Advisors Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$223K Buy
+475
New +$199K 0.12% 128
2018
Q3
Sell
-4,264
Closed -$364K 174
2018
Q2
$364K Sell
4,264
-19
-0.4% -$1.56K 0.24% 91
2018
Q1
$331K Sell
4,283
-1,256
-23% -$101K 0.19% 104
2017
Q4
$468K Sell
5,539
-350
-6% -$29.8K 0.3% 90
2017
Q3
$504K Sell
5,889
-2,238
-28% -$184K 0.35% 84
2017
Q2
$669K Sell
8,127
-817
-9% -$66.7K 0.46% 67
2017
Q1
$752K Buy
8,944
+75
+0.8% +$6.01K 0.56% 53
2016
Q4
$652K Buy
+8,869
New +$660K 0.6% 41

Other funds holding LLY

First Capital Advisors Group's LLY Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Eli Lilly (LLY) in Q2 2023: 475 shares worth $223K. The stake represents 0.12% of the portfolio and ranks #128 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in LLY as recently as Q2 2018.

First Capital Advisors Group first reported a position in LLY in Q4 2016 and has held it in 8 quarters since. The position peaked at $752K in Q1 2017. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • First Capital Advisors Group held 475 shares of Eli Lilly worth $223K as of Q2 2023.
  • Eli Lilly was a new First Capital Advisors Group position in Q2 2023.
  • Eli Lilly made up 0.12% of First Capital Advisors Group's portfolio in Q2 2023, its #128 holding.
  • First Capital Advisors Group first reported a position in Eli Lilly in Q4 2016 and has held it in 8 quarters since.
  • First Capital Advisors Group's Eli Lilly position peaked at $752K in Q1 2017.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.